SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/22/19 Clorox Co/DE 8-K:5 11/20/19 10:217K DG3/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 39K 5: R1 Cover HTML 49K 10: XML IDEA XML File -- Filing Summary XML 11K 8: XML XBRL Instance -- clorox3678131-8k_htm XML 15K 6: EXCEL IDEA Workbook of Financial Reports XLSX 6K 4: EX-101.LAB XBRL Labels -- clx-20191120_lab XML 98K 3: EX-101.PRE XBRL Presentations -- clx-20191120_pre XML 65K 2: EX-101.SCH XBRL Schema -- clx-20191120 XSD 12K 9: JSON XBRL Instance as JSON Data -- MetaLinks 25± 34K 7: ZIP XBRL Zipped Folder -- 0001206774-19-003738-xbrl Zip 12K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): i November 20, 2019
THE CLOROX COMPANY
(Exact name of registrant as specified in its charter)
__________________
i Delaware | i 1-07151 | i 31-0595760 | ||
(State or other jurisdiction of | (Commission File Number) | (I.R.S. Employer | ||
incorporation) | Identification No.) |
i 1221 Broadway, i Oakland,
i California i 94612-1888
(Address
of principal executive offices) (Zip code)
( i 510) i 271-7000
(Registrant's telephone number, including area code)
i Not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading | Name of each exchange on which registered |
Symbol(s) | ||
i Common Stock - $1.00 par value | i CLX | i New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07 Submission of Matters to a Vote of Security Holders.
On November 20, 2019, The Clorox Company (the “Company”) held its annual meeting of stockholders in Pleasanton, California. The matters voted on and the results of the vote were as follows:
1. | The Company’s stockholders elected the following directors to each serve until the next Annual Meeting of Stockholders or until a successor is duly elected and qualified. |
Number of Votes | ||||||||
For | Against | Abstain | Broker Non-Votes | |||||
Amy Banse | 88,139,990 | 569,951 | 218,124 | 21,069,742 | ||||
Richard H. Carmona | 85,595,295 | 3,093,550 | 239,220 | 21,069,742 | ||||
Benno Dorer | 85,233,045 | 3,159,541 | 535,479 | 21,069,742 | ||||
Spencer C. Fleischer | 87,319,078 | 1,330,336 | 278,651 | 21,069,742 | ||||
Esther Lee | 88,115,306 | 568,872 | 243,887 | 21,069,742 | ||||
A.D. David Mackay | 88,331,328 | 330,023 | 266,714 | 21,069,742 | ||||
Robert W. Matschullat | 85,735,605 | 2,928,324 | 264,136 | 21,069,742 | ||||
Matthew J. Shattock | 88,071,571 | 600,545 | 255,949 | 21,069,742 | ||||
Pamela Thomas-Graham | 85,531,713 | 3,169,072 | 227,280 | 21,069,742 | ||||
Russell Weiner | 87,791,923 | 879,359 | 256,783 | 21,069,742 | ||||
Christopher J. Williams | 88,042,111 | 628,369 | 257,585 | 21,069,742 |
2. | The Company’s stockholders voted for (on an advisory basis) the approval of the compensation of the Company’s named executive officers. |
Number of Votes | |||||||
For | Against | Abstain | Broker Non-Votes | ||||
81,851,649 | 6,406,875 | 669,259 | 21,070,024 |
3. | The Company’s stockholders ratified the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2020. |
Number of Votes | |||||||
For | Against | Abstain | Broker Non-Votes | ||||
107,970,846 | 1,629,225 | 397,736 | 0 |
4. | The Company’s stockholders did not approve the proposed amendment to the Company’s Restated Certificate of Incorporation to eliminate the supermajority voting provision. Under the Company’s Restated Certificate of Incorporation, the affirmative vote of at least 80% of the outstanding voting stock is required to approve this proposal. The 87,544,878 votes in favor of this proposal represented 69.76% of the total outstanding shares of common stock. |
Number of Votes | |||||||
For | Against | Abstain | Broker Non-Votes | ||||
87,544,878 | 866,508 | 516,679 | 21,069,742 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
THE CLOROX COMPANY | |||
Date: November 22, 2019 | By: | /s/ Laura Stein | |
Executive Vice President – | |||
General Counsel and Corporate Affairs |
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
6/30/20 | 10-K, 4 | |||
Filed on: | 11/22/19 | 4 | ||
For Period end: | 11/20/19 | DEF 14A, PRE 14A | ||
List all Filings |